Article

AFib: Early Ablation Gets Dramatic Results, Cleveland Clinic Finds

Author(s):

Patients with atrial fibrillation do significantly better when catheter ablation is done quickly, Cleveland Clinic researchers found.

Patients with atrial fibrillation (AF) do significantly better when catheter ablation is done quickly, Cleveland Clinic researchers found. The patients who got earlier ablation showed less inflammation, hemodynamic strain, and atrial dilation (remodeling).

In a study published Jan. 13 in Circulation: Arrhythmia and Electrophysiology Ayman Hussein, MD, and colleagues assessed two-year outcomes for 1,241 patients undergoing first-time ablation for persistent AF. Patients with paroxysmal AF were excluded. Patients had to have failed at least one antiarrhythmic medication to be included in the study.

They gave patients echocardiograms and measured B-type natriuretic peptide and C-reactive protein before procedures. The median time between the patients’ getting a diagnosis of AF and having and ablation procedure was three years.

The procedure was done under an AF ablation protocol that involved continuing therapeutic anticoagulation. Doctors used a phased-array intravascular ultrasound catheter placed in the right atrium to assist with performing trans-septal punctures, guide catheter location and manipulation with then left atrium, and monitor for complications.

The end point of the procedures was complete isolation of the pulmonary veins and superior vena cava and demonstration of absence of LA triggers in sinus rhythm.

The team found that the longer patients waited to get the procedure, the poorer the outcome.

The researchers divided the study population using the time intervals between first persistent AF diagnosis and ablation. Those time quartiles were less than 1 year, 1.1 -3 years, 3.1-6.5 years, and more than 6.5 years.

The findings did not differ with patients’ age, sex, and risk factors for recurrence, the team found.

In those who had ablation within a year of persistent AF diagnosis, 33.6% had recurrence of arrhythmia. In those who the procedure within three years of diagnosis 52.6 % had recurrence of arrhythmia. If patients waited from 3.1 years to 6.5 years, the rate of recurrence of arrhythmia was 57.1%.

The percentage of patients who had a recurrence dropped slightly to 54.6% after 6.5 years.

“In patients with persistent AF undergoing ablation, the time interval between the first diagnosis and the catheter ablation procedure had a strong association with the ablation outcomes,” they concluded.

Shorter diagnosis-to-ablation times “were associated with better outcomes and in direct association with markers of atrial remodeling,” they noted.

The authors are hopeful that their study might change standard practice in treating persistent AF. The heart ailment affects about 2.7 million people in the US.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
Orly Vardeny, PharmD | Credit: JACC Journals
© 2024 MJH Life Sciences

All rights reserved.